Skip to main content

Table 5 Clinical, histopathological, therapeutic, evolutional, therapeutic and laboratory data of 25 patients from Northeastern Brazil diagnosed with granulomatosis with polyangiitis (GPA) between 2005 and 2016

From: Granulomatosis with polyangiitis in Northeastern Brazil: study of 25 cases and review of the literature

Patient

Sex

1stM → D

(months)

Clinical manifestations

Current 24-h UPO

ANCA

Biopsy

Therapy

1

F

6

nephritic syndrome, hemoptysis, CKD

1461

c-Anca + Tu

n/a

CS, CFM

2

F

1

Hemoptysis, nephritic syndrome, AKI, purpura, sinusitis, mastoiditis, acral necrosis

816

c-Anca + 1:80

n/a

CS, CFM

3

F

3.5

sinusitis, scleritis, multiple mononeuritis, pulmonary nodule, polyneuropathy, CHF, nephritic syndrome; AKI

3760

c-Anca + Tu

Pulmonary nodule: granulomatous vasculitis with OP

CS, CFM, RTX

4

M

6

laryngitis, sinusitis, pulmonary nodule, hemoptysis, upper respiratory tract stenosis

150

c-Anca + 1:320

n/a

CS, CFM, RTX

5

F

66

sinusitis, polyarthritis, purpura laryngitis, bronchial stenosis

130

c-Anca -

Skin: LCV

CS, CFM

6

F

0.5

sinusitis, CKD, alveolar hemorrhage, death

n/a

c-Anca + 1:640

n/a

CS, CFM

7

F

84

sinusitis, polyarthritis, saddle nose deformity, pulmonary nodule

74

c-Anca -

Nasal mucosa: granulomatous vasculitis

CS

8

F

36

multiple mononeuritis, transverse myelitis, neurosensory deafness, sinusitis, uveitis, polyarthritis,, polyneuropathy, laryngitis, pulmonary nodule

150

c-Anca -

n/a

CS, CFM, RTX

9

F

216

sinusitis, saddle nose deformity nephritic syndrome, polyarthritis, dialytic AKI

n/a

c-Anca + 1:40

n/a

CS

10

F

12

neurosensory deafness, polyarthritis, nephrotic syndrome, nephritic syndrome, epistaxis, dialytic CKD, alveolar hemorrhage, death

385

c-Anca + 1:160

n/a

CS, AZA, RTX

11

M

120

polyarthritis, purpura; sinusitis, orbital pseudotumor, otitis media, pericardial effusion

64

c-Anca + Tu

n/a

CS, AZA, RTX

12

F

0.5

polyarthritis, nephritic syndrome; epistaxis, mastoiditis, scleritis, pulmonary nodule, facial nerve paralysis, CKD, mitral insufficiency

1680

c-Anca + 1:160

Bronchial lesion: granulomatous vasculitis

CS, AZA

13

M

5

neurosensory deafness, polyneuropathy, polyarthritis, purpura, acral necrosis, nephritic syndrome; pulmonary nodule

150

c-Anca + 1:640

Sural nerve: granulomatous vasculitis

CS, AZA

14

F

5

neurosensory deafness, sinusitis, nephritic syndrome, pulmonary nodule

1078

c-Anca + 1:40

Kidney: diffuse proliferative GN

CS, CFM

15

F

192

scleritis, polyarthritis, epistaxis, orbital pseudotumor, sinusitis, hemoptysis, AKI, amaurosis

511

p-Anca + 1:640

Kidney: acute tubular necrosis

CS, CFM

16

F

42

nodular scleritis, neurosensory deafness, polyarthritis, pulmonary nodule, third-degree AVB, cutaneous nodule

200

c-Anca + 1:640

Skin: Churg-Strauss granuloma; pulmonary nodule: granulomatous vasculitis with OP

CS, CFM

17

F

120

Purpura, hemoptysis, cutaneous nodule, polyarthritis, CKD, orbital pseudotumor,

900

c-Anca + 1:320

Nasal mucosa: granulomatous vasculitis

CS, CFM, AZA, RTX

18

F

0.5

purpura, pulmonary-renal syndrome, death

n/a

c-Anca + 1:320

Skin: LCV

CS, IMGN

19

M

1

polyarthritis, nephrotic syndrome, pulmonary-renal syndrome, death

26,350

c-Anca + 1:80

Bronchial: granulomatous vasculitis

CS, CFM, PLASMF

20

F

1

sinusitis, purpura, polyarthritis, nephritic syndrome

775

c-Anca + 1:640

Kidney: FSGS

CS, CFM, RTX

21

F

120

hemoptysis, otitis media, sinusitis

140

c-Anca + 1:640

n/a

CS, AZA, RTX

22

F

32

Raynaud phenomen, vertigo, polyneuropathy, purpura, sinusitis

150

c-Anca + 1:20

Skin: LCV

CS, AZA

23

F

3

polyarthritis, hemoptysis, nephritic syndrome, AKI, nephrotic syndrome

4300

c-Anca + 1:160

Kidney: pauci-immune crescentic GN

CS, RTX

24

F

n/a

sinusitis, anosmia, pulmonary fibrosis

n/a

p-Anca + 1:640

n/a

CS, CFM

25

F

3

Scleritis, purpura, polyarthritis, sinusitis, Cushing’s syndrome

n/a

c-Anca + 1:80

Skin: LCV

CS, MTX

  1. M male, F female, 1stM → D time in months from first manifestation of GPA to diagnosis, ANCA antineutrophil cytoplasmic antibodies, UPO urine protein output, CFM cyclophosphamide, RTX rituximab, AZA azathioprine, CS corticosteroids, AKI acute kidney injury, IMGN immunoglobulin, PLASM plasmapheresis, GN glomerulonephritis, CKD chronic kidney disease, AVB atrioventricular block, CHF congestive heart failure, OP organizing pneumonia, LCV leukocytoclastic vasculitis, Tu titer unavailable, FSGS focal segmental glomerulosclerosis